Cargando…

Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study

BACKGROUND: Diabetes is a cause of at least a third of all deaths in Mexican adults aged 35–74 years, with the excess mortality due mainly to vascular disease, renal disease, infection, and acute diabetic crises. We aimed to analyse the effect of diabetes duration and glycaemic control on death rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herrington, William G, Alegre-Díaz, Jesus, Wade, Rachel, Gnatiuc, Louisa, Ramirez-Reyes, Raúl, Hill, Michael, Solano-Sánchez, Martha, Baigent, Colin, Lewington, Sarah, Collins, Rory, Tapia-Conyer, Roberto, Peto, Richard, Kuri-Morales, Pablo, Emberson, Jonathan R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Lancet, Diabetes & Endocrinology 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966587/ https://www.ncbi.nlm.nih.gov/pubmed/29567074 http://dx.doi.org/10.1016/S2213-8587(18)30050-0

Ejemplares similares

Association of Blood Pressure With Cause-Specific Mortality in Mexican Adults
por: Tapia-Conyer, Roberto, et al.
Publicado: (2020)

Adiposity and Blood Pressure in 110 000 Mexican Adults
por: Gnatiuc, Louisa, et al.
Publicado: (2017)

Abdominal and gluteo-femoral markers of adiposity and risk of vascular-metabolic mortality in a prospective study of 150 000 Mexican adults
por: Gnatiuc, Louisa, et al.
Publicado: (2021)

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults
por: Aguilar-Ramirez, Diego, et al.
Publicado: (2022)

Body mass index and COVID-19 mortality: prospective study of 120 000 Mexican adults
por: Alegre-Díaz, Jesus, et al.
Publicado: (2022)

Changes in the Diagnosis and Management of Diabetes in Mexico City Between 1998–2004 and 2015–2019
por: Aguilar-Ramirez, Diego, et al.
Publicado: (2021)

Association of Kidney Function With NMR-Quantified Lipids, Lipoproteins, and Metabolic Measures in Mexican Adults
por: Aguilar-Ramirez, Diego, et al.
Publicado: (2021)

Body Composition and Risk of Vascular‐Metabolic Mortality Risk in 113 000 Mexican Men and Women Without Prior Chronic Disease
por: Gnatiuc Friedrichs, Louisa, et al.
Publicado: (2023)

Low-intensity daily smoking and cause-specific mortality in Mexico: prospective study of 150 000 adults
por: Thomson, Blake, et al.
Publicado: (2021)

The prevalence of chronic diseases and major disease risk factors at different ages among 150 000 men and women living in Mexico City: cross-sectional analyses of a prospective study
por: Kuri-Morales, Pablo, et al.
Publicado: (2009)

Diabetes and infectious disease mortality in Mexico City
por: Bragg, Fiona, et al.
Publicado: (2023)

Educational and social inequalities and cause-specific mortality: a prospective study in two municipalities of Mexico City
por: Addey, Thomas, et al.
Publicado: (2023)

Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank
por: Zhu, Pengfei, et al.
Publicado: (2020)

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2019)

Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
por: Herrington, William, et al.
Publicado: (2015)

Childhood Smoking, Adult Cessation, and Cardiovascular Mortality: Prospective Study of 390 000 US Adults
por: Thomson, Blake, et al.
Publicado: (2020)

Introducing a Dengue Vaccine to Mexico: Development of a System for Evidence-Based Public Policy Recommendations
por: Betancourt-Cravioto, Miguel, et al.
Publicado: (2014)

Association Between Smoking, Smoking Cessation, and Mortality by Race, Ethnicity, and Sex Among US Adults
por: Thomson, Blake, et al.
Publicado: (2022)

Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
por: Mihaylova, Borislava, et al.
Publicado: (2016)

Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease
por: Herrington, William, et al.
Publicado: (2017)

Effect of Exercise Duration on Postprandial Glycaemic and Insulinaemic Responses in Adolescents
por: Dring, Karah J., et al.
Publicado: (2020)

para tu Salud: Reduction of Weight and Waistlines by Integrating Exercise Breaks into Workplace Organizational Routine
por: Yancey, Antronette K, et al.
Publicado: (2007)

Evaluation of effective coverage for type 2 diabetes in Mexican primary care health information systems: a retrospective registry analysis
por: Gallardo-Rincón, Héctor, et al.
Publicado: (2023)

Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
por: Morton, Rachael L., et al.
Publicado: (2016)

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials
por: Staplin, Natalie, et al.
Publicado: (2021)

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes
por: Nag, Abhishek, et al.
Publicado: (2022)

A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
por: Schlackow, Iryna, et al.
Publicado: (2017)

Evaluating the Contribution of the Cause of Kidney Disease to Prognosis in CKD: Results From the Study of Heart and Renal Protection (SHARP)
por: Haynes, Richard, et al.
Publicado: (2014)

What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
por: Kent, Seamus, et al.
Publicado: (2015)

Impact of CKD on Household Income
por: Morton, Rachael L., et al.
Publicado: (2017)

Impact of Outcome Adjudication in Kidney Disease Trials: Observations From the Study of Heart and Renal Protection
por: Herrington, William G., et al.
Publicado: (2023)

The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control
por: Casanova, F., et al.
Publicado: (2017)

Factors associated with longer breastfeeding duration in Mexican working mothers
por: Ibarra-Ortega, Anel, et al.
Publicado: (2021)

Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis
por: Mafham, Marion, et al.
Publicado: (2011)

Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) – results of a randomized controlled clinical trial
por: Haynes, Richard, et al.
Publicado: (2018)

The joint effects of apolipoprotein B, apolipoprotein A(1), LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls†
por: Parish, Sarah, et al.
Publicado: (2009)

Glycaemic Effects of Non-statin Lipid-Lowering Therapies
por: Collins, Patrick D., et al.
Publicado: (2016)

El manual de salud pública /
por: Tapia Conyer, Roberto
Publicado: (2004)

El manual de salud pública /
por: Tapia Conyer, Roberto
Publicado: (2005)

Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
por: Storey, Benjamin C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0jlpdffhtbuav90nbmi2eg863k